Status:
COMPLETED
Biomarkers to Distinguish Benign From Malignant Thyroid Neoplasm
Lead Sponsor:
Norman Eberhardt
Conditions:
Cancer of the Thyroid
Neoplasms, Thyroid
Eligibility:
All Genders
18-90 years
Brief Summary
This protocol will evaluate microRNA biomarkers in blood and fine-needle aspirate biopsies (FNAB) of thyroid nodules. MicroRNA profiles will be determined and evaluated for their utility in pre-operat...
Detailed Description
This protocol requires the collection of blood (5 ml), fine-needle aspirate biopsies (FNAB), and post-surgical thyroid cancer tissue. The post surgical tissue includes fresh-frozen tissue that is cons...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patient with palpable thyroid nodule suspicious for thyroid neoplasm
- Patient selected to undergo fine needle biopsy for cytologic diagnosis
- Male (18 years of age or older)
- Female (18 years of age or older)
Exclusion
Key Trial Info
Start Date :
June 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT01433809
Start Date
June 1 2011
End Date
May 1 2013
Last Update
January 22 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905